17 Hrs
Source:
مأرب برس
Security alert: Houthi messages target liberated areas via Yemen Mobile and Yoo
The article indicates that Eurovizer plans to launch a new COVID-19 vaccine by 2026, following its successful development of an effective vaccine against the Omicron variant. The company aims to produce over 344 million doses annually, with expectations that the vaccine will help reduce infection and death rates, in response to the virus's ongoing evolution and mutation. The company is targeting enhanced herd immunity by providing more effective options to combat the COVID-19 pandemic.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)